The utility of PET/CT in the management of patients with colorectal liver metastases undergoing laparascopic radiofrequency thermal ablation

Annals of Surgical Oncology

Volumn 19, Issue 3, 2012, Pages 850-855

  Sahin, Dursun Ali ^a   Agcaoglu, Orhan ^a   Chretien, Celia ^a   Siperstein, Allan ^a   Berber, Eren ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHI SQUARE TEST; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; KAPLAN MEIER METHOD; LAPAROSCOPY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODEL; RADIOFREQUENCY ABLATION; RADIOFREQUENCY THERMAL ABLATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STUDENT T TEST; TREATMENT PLANNING; TUMOR LOCALIZATION; CATHETER ABLATION; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SCINTISCANNING; SURVIVAL RATE; TUMOR RECURRENCE;

CATHETER ABLATION; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LAPAROSCOPY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84862292703     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2059-7     Document Type: Article

References (14)

1. Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007;246:559-65; discussion 565-7.
2. Kierans AS, Elazzazi M, Braga L, Leonardou P, Gerber DA, Burke C, et al. Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. AJR Am J Roentgenol. 2010;194:523-9.
3. Foroutani A, Garland AM, Berber E, String A, Engle K, Ryan TL, et al. Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg. 2000;135: 933-8. (Pubitemid 30625971)
4. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med. 2000;41:1177-89. (Pubitemid 30464000)
5. Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer. 2005;104: 2658-70. (Pubitemid 41798276)
6. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240:438-47; discussion 447-50.
7. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg. 2004;240:1027-34; discussion 1035-6.
8. Donckier V, Van Laethem JL, Goldman S, Van Gansbeke D, Feron P, Ickx B, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol. 2003;84:215-23. (Pubitemid 37484786)
9. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med. 2003;28:192-7. (Pubitemid 38281975)
10. Kuehl H, Antoch G, Stergar H, Veit-Haibach P, Rosenbaum-Krumme S, Vogt F, et al. Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Eur J Radiol. 2008;67: 362-71.
11. Kuehl H, Stattaus J, Hertel S, Hunold P, Kaiser G, Bockisch A, et al. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours - a single-centre experience. Clin Oncol (R Coll Radiol). 2008;20:234-40.
12. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol. 2006;16:80-7. (Pubitemid 43103572)
13. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol. 2005;23:1358-64.
14. Glazer ES, Beaty K, Abdalla EK, Vauthey JN, Curley SA. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases. Arch Surg. 2010;145:340-5; discussion 345.